143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
Study finds multiple disparities in completing care after concussions

Study finds multiple disparities in completing care after concussions

by Children's Hospital of PhiladelphiaCredit: Unsplash/CC0 Public DomainResearchers from Children's Hospital of Philadelphia (CHOP) found disparities in the completion of follow-up concus

Study finds multiple disparities in completing care after concussions

by Children's Hospital of PhiladelphiaCredit: Unsplash/CC0 Public DomainResearchers from Children's Hospital of Philadelphia (CHOP) found disparities in the completion of follow-up concus
Dementia screening test adapted for people with hearing problems

Dementia screening test adapted for people with hearing problems

by University of QueenslandReceiver operating characteristic (ROC) curve analysis of the Montreal Cognitive Assessment for people with hearing impairment (MoCA-H), with and without adjustment for

Dementia screening test adapted for people with hearing problems

by University of QueenslandReceiver operating characteristic (ROC) curve analysis of the Montreal Cognitive Assessment for people with hearing impairment (MoCA-H), with and without adjustment for
Holiday stress can lead Alzheimer's patients and those with dementia to go missing

Holiday stress can lead Alzheimer's patients and those with dementia to go missing

by Shelia PooleCredit: Pixabay/CC0 Public DomainHolidays are a time for families and friends to gather, but for older people with Alzheimer's disease and other dementias, it can cause so much stre

Holiday stress can lead Alzheimer's patients and those with dementia to go missing

by Shelia PooleCredit: Pixabay/CC0 Public DomainHolidays are a time for families and friends to gather, but for older people with Alzheimer's disease and other dementias, it can cause so much stre
Study highlights need for non-motor care in stroke recovery

Study highlights need for non-motor care in stroke recovery

byUniversity College LondonPrevalence of adverse non-motor outcomes. Credit:The Lancet Regional Health—Europe(2024). DOI: 10.1016/j.lanepe.2024.101080Care for stroke survivors urgent

Study highlights need for non-motor care in stroke recovery

byUniversity College LondonPrevalence of adverse non-motor outcomes. Credit:The Lancet Regional Health—Europe(2024). DOI: 10.1016/j.lanepe.2024.101080Care for stroke survivors urgent
Neuro/psych diagnoses prevalent in children with medical complexity

Neuro/psych diagnoses prevalent in children with medical complexity

by Elana GotkineChildren with medical complexity (CMC) often have neurodevelopmental and mental health diagnoses, which are associated with increased health care utilization, according to a study&nbsp

Neuro/psych diagnoses prevalent in children with medical complexity

by Elana GotkineChildren with medical complexity (CMC) often have neurodevelopmental and mental health diagnoses, which are associated with increased health care utilization, according to a study&nbsp
Alternative understanding of brain leads to new treatments for stroke patients

Alternative understanding of brain leads to new treatments for stroke patients

by Aaron Wagner,Pennsylvania State UniversityThe idea of complimentary dominance — both hemispheres of the brain contribute to different aspects of movement in both halves of the body — was deve

Alternative understanding of brain leads to new treatments for stroke patients

by Aaron Wagner,Pennsylvania State UniversityThe idea of complimentary dominance — both hemispheres of the brain contribute to different aspects of movement in both halves of the body — was deve
Researchers mark milestone in progress toward investigational new drug for triple-negative breast cancer

Researchers mark milestone in progress toward investigational new drug for triple-negative breast cancer

by Leslie Cantu,Medical University of South CarolinaDr. Ozgur Sahin, center, with first authors Drs. Ozge Saatci and Metin Cetin. Credit: MUSC Hollings Cancer CenterA new compound developed by r

Researchers mark milestone in progress toward investigational new drug for triple-negative breast cancer

by Leslie Cantu,Medical University of South CarolinaDr. Ozgur Sahin, center, with first authors Drs. Ozge Saatci and Metin Cetin. Credit: MUSC Hollings Cancer CenterA new compound developed by r
Neural circuits reveal new insights into how we navigate space and store memories

Neural circuits reveal new insights into how we navigate space and store memories

by Pat Harriman,University of California, IrvineDistinct RSC neuronal circuits corresponding to M2- and AD-projection neurons revealed by retrograde adeno-associated (rAAV2-retro) virus and ante

Neural circuits reveal new insights into how we navigate space and store memories

by Pat Harriman,University of California, IrvineDistinct RSC neuronal circuits corresponding to M2- and AD-projection neurons revealed by retrograde adeno-associated (rAAV2-retro) virus and ante
Drug target for Alzheimer's disease has dual action

Drug target for Alzheimer's disease has dual action

by Queensland Brain InstituteCredit: Queensland Brain InstituteResearchers have discovered a potential drug target for Alzheimer's disease—an enzyme which has effects on both the immune and nervou

Drug target for Alzheimer's disease has dual action

by Queensland Brain InstituteCredit: Queensland Brain InstituteResearchers have discovered a potential drug target for Alzheimer's disease—an enzyme which has effects on both the immune and nervou
Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not